YTHDF2 and lung adenocarcinoma: As for AXIN1, Li et al. revealed YTHDF2 participated in the progression of lung adenocarcinoma (LUAD) through upregulating he AXIN1/Wnt/β-catenin signaling, which might provide a new treatment strategy of LUAD [36].